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ABSTRACT (261 words)   
Background: Bacterial skin and soft tissue infections (SSTI) among people who 
inject drugs (PWID) are considered a public health concern.  There is a lack of 
qualitative research examining the lived experience of PWID who have had SSTI.  
This paper explores PWID views and experiences of their SSTI, their perceptions on 
the causes of their SSTI and their harm reduction (HR) behaviours.  The implications 
for HR service delivery and practice will be discussed. 
 
Methods: Between October 2015-January 2016, 22 in-depth interviews were 
conducted with PWID who had experienced a SSTI within the past year.  
Interviewees were recruited from an injecting equipment provision service and a drug 
treatment service in Glasgow and Edinburgh respectively.  The interview transcripts 
were transcribed verbatim and underwent thematic analysis.  
 
Results: We found that the experience of SSTI can cause strong negative feelings, 
including panic and stigma and that there was limited knowledge of SSTI prior to first 
hand experience. The awareness of the unacceptable social and physical 
consequences of SSTI fostered a sense of personal responsibility and agency which 
led to the introduction or improved HR uptake. However, when PWID were struggling 
Page 3 of 30 
 
to inject or when their physical and political environments were compromised there 
was an increased risk for SSTI and reduced effectiveness of HR.   
 
Conclusion: Compared to HCV and HIV, SSTI as an injecting related harm has 
received less policy attention. Policy makers need to address SSTI HR within 
enabling environments, such as ‘safer environment interventions’. It is recommended 
that peer based support, improved NSP provision and medically supervised injecting 
facilities are needed to deliver SSTI HR. 
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INTRODUCTION  
Skin and soft tissue infections (SSTI) among people who inject drugs (PWID) are 
considered a public health concern.  Injection site SSTI are typically caused by 
bacteria on the skin from unsterile injecting equipment or contaminated drugs 
(Gordon & Lowy, 2005). If these infections, which typically result in abscesses or 
cellulitis, are left untreated they can result in serious morbidity and mortality; in 
addition, infections (such as anthrax and botulism) caused by spore forming bacteria 
(SFB) can be fatal because of the toxins produced and require prompt medical 
attention  (Hope, 2010). 
 
A systematic review of international prevalence studies has shown that SSTI are 
common among PWID; between 6 to 32% of PWID reported a current SSTI or 
having had one within the past month, and 7 to 37% reported an SSTI within the past 
6 to 12 months (Larney, Peacock, Mathers, Hickman, & Degenhardt, 2017).  Despite 
this, much of the harm reduction (HR) aimed at PWID has arisen from, and remains 
focussed on, the prevention of HCV (Hepatitis C virus) and HIV leaving SSTI as the 
neglected injecting related harm (Hope, 2010). 
The growing body of literature on SSTI among PWID has been dominated by 
quantitative cross sectional studies, aimed at identifying risk factors associated with 
SSTI prevalence, and clinical case-reports.  These studies have identified a number 
of risk factors: including being female, frequent injecting, and intra-muscular or 
subcutaneous injecting; whilst skin swabbing and hand washing were identified as 
protective factors (Larney et al., 2017).  A limited number of behavioural change 
intervention studies have examined SSTI; including brief interventions addressing 
injection site cleaning, hand cleaning or needle bleaching (Mercure, Tetu, Lamonde, 
Page 5 of 30 
 
& Cote, 2008; Phillips, Stein, Anderson, & Corsi, 2012). However, HR behaviours 
learned through such brief interventions may become irrelevant within the everyday 
life of a PWID (Miller, 2005). Studies examining the impact of structural interventions, 
such as injecting equipment provision, on SSTI have also been limited and 
quantitative in design (Larney et al., 2017). Although these quantitative studies 
highlight the associations between risk or protective factors and SSTI, qualitative 
studies are needed to help understand the many explanations within the PWIDs’ 
lived experiences for such associations (Tim Rhodes & Coomber, 2010). 
There is a lack of qualitative work examining SSTI and HR apart from a recent study 
by Phillips et al. (Phillips, Altman, Corsi, & Stein, 2013). Phillips et al.’s focus groups 
found that PWID in Denver USA believed that drug composition, intra-muscular 
injection and re-using needles caused skin abscesses; and that limited access to 
injecting equipment, withdrawal and a lack of advanced injecting planning and 
preparation were barriers to HR engagement.  The aim of this paper was to explore 
PWID experiences and views of their SSTI, their perceptions on the causes of their 
SSTI and their HR behaviours. These findings will be drawn upon to discuss the 
implications for existing and future HR service delivery and practice.  
 
METHODS  
Research design 
A qualitative approach, using in-depth interviewing, was adopted due to the 
exploratory nature of this research and to capture the lived experiences of PWID. 
Two research sites were chosen including a drug treatment centre located in NHS 
Lothian Health Board with access to a mobile needle and syringe exchange 
programme (NSP) and a wound clinic, and a pharmacy based NSP service located 
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within NHS Greater Glasgow and Clyde Health Board. These research sites were 
chosen as these Health Boards have sizeable injecting populations and unpublished 
survey data indicated the proportion of PWID reporting an SSTI in the past year was 
36% and 27% respectively (unpublished University of the West of Scotland & NHS 
Health Protection Scotland Needle Exchange Surveillance Initiative (2013) data). 
These areas had also recently experienced clusters/outbreaks of bacterial infections. 
Within NHS Greater Glasgow and Clyde there was a botulism cluster/outbreak 
during Dec 2014-July 2015 (NHS National Services Scotland, 2017) and in NHS 
Lothian there was a Group A Streptococcus cluster/outbreak associated with 
ethylphenidate, a new psychoactive substance (NPS) during 2014-2015 (Yeung et 
al., 2017).   
 
Sampling and recruitment 
Staff at the research sites facilitated recruitment by initially informing their clients 
about the study and the availability of the researcher.  The researcher explained the 
nature of the study to possible participants and checked eligibility. Eligible 
participants were those who were 18 years or older, had injected in the past six 
months and had experienced a SSTI within the past year.  SSTI were defined as 
abscesses, cellulitis or necrotising fasciitis caused by injecting. Photographs of 
localised SSTI symptoms and descriptions of local and systemic symptoms were 
used to help identify the nature of the SSTI experienced. Purposive sampling was 
used to recruit PWID by SSTI and by gender. Exclusion criteria included those 
younger than 18 years. 
 
Data collection  
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In-depth interviews, lasting between 21 and 67 minutes, were undertaken in a private 
consulting room at the recruitment sites between October 2015 and January 2016. A 
short questionnaire was used to gather non-identifiable demographics, drug use and 
opiate substitution treatment history within the past six months.  A topic guide 
explored PWID’s experiences and views of SSTI including clusters/outbreaks of SFB 
infections, how they responded to their infection in terms of HR, healthcare seeking 
and self-treatment. The interview focussed on the most recent and/or most severe 
SSTI experienced.   
 
Analysis 
All interviews were digitally recorded, transcribed verbatim and pseudonyms 
assigned.  The transcripts were categorised thematically using framework analysis 
(Ritchie, Lewis, McNaughton Nicholls, & Ormston, 2014). Framework analysis, which 
consists of data management and data analysis is a useful technique for the 
formulation of policy (Tim Rhodes & Coomber, 2010; Ritchie et al., 2014).   
 
Microsoft WORD was used to manage the data. The lead author checked the 
transcripts and recordings for accuracy and familiarisation of the data, developed the 
initial framework by applying the topic guide to create categories to help sift and sort 
the data. The study team agreed the coding framework. The lead author indexed 
each transcript using these framework categories. Matrices were developed for each 
framework category where the participants’ interviews were summarized within the 
matrix. This enabled analysis of a category across all participants or analysis across 
the categories by a single participant. Data analysis consisted of mapping the range 
of responses and looking for patterns in the matrices and links between categories. 
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From this a number of themes emerged including: impact of SSTI; knowledge of 
SSTI; personal responsibility and agency; social and physical risk environment. 
Rhodes’ theory of risk environment was used to help interpret and explain the 
findings to aid a policy level discussion on the need and direction for SSTI HR 
interventions (Tim Rhodes, 2002, 2009).  The ‘risk environment’ framework enables 
an examination of the physical, social, economic and political environments that 
influence injecting practices and disrupt HR uptake.  These four dimensions operate 
at a micro and macro level. The ‘risk environment’ shapes the success or failure of 
HR interventions (Tim Rhodes, 2002). Descriptive statistics were used to describe 
the participants’ demographics. 
 
Ethics 
NHS West of Scotland Research Ethics Committee and the University of the West of 
Scotland Ethics Committee granted ethical approval.  Participants were given an 
information sheet and provided informed consent prior to data collection. Participants 
were offered a £25 retail voucher for their time.  
 
 
FINDINGS  
Participant characteristics 
Twenty two PWID were interviewed between Glasgow (n=14) and Edinburgh (n=8).  
The median age was 36.5 years (range 21 to 61 years), 68% (15) were male and 
59% (13) had experienced homelessness during the past six months.  They had 
been injecting for a median of 15.5 years (range 5 to 43 years). All participants had 
injected heroin within the past six months, for 82% (18) this was the main drug 
Page 9 of 30 
 
injected; for one participant cocaine was their main drug, and for another one it was 
NPS and heroin equally taken. The majority (82%, 18) were injecting at least daily. 
Between all participants, a total of 23 abscesses, three cellulitis and two necrotising 
fasciitis infections were experienced in the past year.  
 
Impact of SSTI 
SSTI typically caused many strong negative feelings among the majority of 
participants whilst only a few participants felt unconcerned. 
 
Dave, for example, who had experienced abscesses intermittently over the past 25 
years, showed no concern for abscesses, describing SSTI to be an inevitable 
consequence of injecting:   
It’s all part and parcel of, it’s just a, another sort of hazard a’ drug taking. 
(Dave, Male, 40 year old) 
This suggests that some PWID normalise SSTI. However, this view that injecting 
related harm, such as abscesses, is normal or inevitable (Morrison, Elliott, & Gruer, 
1997)  belies the strong negative psychological suffering that can be experienced by 
PWID with SSTI. In contrast to Dave’s unconcern, others felt panicked or stigmatised 
by the symptoms.   
Feelings of panic were linked to physical consequences such as a fear of losing a 
limb, which was a commonly held view, or from lack of healing and potential 
poisoning of the body. Fear of losing a limb was illustrated by Brian who had 
cellulitis: 
I What is it about it that – what is it that makes you worry about it? 
R Just the infection an’ everything. Do you know what I mean? Because 
 you don’t know what it could be . . . .You might end up losing a limb. 
 (Brian, Male, 42 years old) 
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In addition to the fear of the possible physical outcomes of SSTI, PWID also felt 
stigmatised by them. This stigma could be internalised, as demonstrated by Holly: 
And I feel conscious about it and I hate myself for it.  So it makes me feel, it 
makes me feel horrible.  Ugly and horrible and, you know.  It’s no nice.  But 
it’s self inflicted, but it’s ma own fault, you know. (Holly, Female, 36 years old) 
 
But, like HCV and HIV, which stigmatise PWID by association with injecting (Treloar 
& Rhodes, 2009), SSTI were also socially stigmatising, but in a much more visual 
way, by potentially identifying a PWID because of the unsightly visible physical 
symptoms: 
But see when I’ve got poison in them an’ they’re green an’ yellow an’ that, you 
dinnae like any, naebody tae [you don’t like anyone to] actually see that.  It’s 
horrible, it’s like a deformity on you. . . . [A]s if somebody would go, “Aye, you 
can tell he’s jagging.  Look, you can tell he’s injecting drugs because look at 
his legs.”  . . . it stops you fae wearing shorts or things like that on a hot day or 
whatever, eh? (Danny, Male, 43 years old) 
 
Knowledge of SSTI 
Concern, or lack of it, about the physical aspects of SSTI appeared to be linked to 
level of knowledge about SSTI. Dave, mentioned above as showing no concern, had 
gained knowledge from having had abscesses over 25 years: 
I knew a fair lot cause I had a fair few [laughs].  (Dave, Male, 40 year 
old) 
And Alison, who was also unconcerned about her abscess, had gained awareness 
from seeing or hearing about abscesses from her social network:   
I wasn’t overly worried about it because I knew that it was acting as the same 
way as ma other friends. (Alison, Female, 36 year old) 
In contrast, among some PWID there was very little second hand learning of SSTI 
from peers:  
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I’d seen folk wi’ them and that eh.  But I just never knew anything aboot 
them eh. (Bobby, Male, 32 year old) 
My ex boyfriend, he had an abscess.  [I] Never ever looked at it.  But 
he was always on about abscess[es].  I didnae [did not] ask him any 
questions or anything like that.  Just…but aye and then I got one 
maself.  (Tanya, Female, 21 years old) 
Consequently, those who experienced a SSTI for the first time demonstrated a lack 
of knowledge as exemplified by Allan, who had been injecting for 16 years before 
experiencing his first abscess:  
I didn’t know anything about them until it happened. … Until I got, 
[NAME of FRIEND] knew about them but he didn’t tell me until 
something happened. … Cause I, I asked him.  I was like, ‘what the 
hell’s that on my arm?’  He’s like, ‘it’s an abscess’. (Allan, Male, 34 
year old) 
A lack of second-hand learning from other peoples’ experiences reflected a 
disinterest until SSTI became relevant:  
Ken, it was nowt tae dae wi’ me [Do you know what I mean, it was 
nothing to do with me], until I started getting them an’ then I started 
realising “Oh here, he must have got that through the… here mate, 
how did you get that?”  Aye, it’s just I’ve got one there an’ you can, 
sometimes you compare, eh? (Danny, Male, 43 years old) 
For some this disinterest arose from a belief that they would never suffer from a 
SSTI as illustrated by Bobby:  
Aye that’ll never happen tae me.  I had the attitude, that was the attitude I 
had.  ‘That’ll never happen tae me’.  I’m the lucky one and that, it’ll no happen 
tae me.  . . .  (Bobby, Male, 32 years old)  
Interestingly, Bobby was unwilling to share his experience of his groin abscess with 
his social network, an approach which  helps explain  a lack of second-hand 
learning: 
 I didnae [I didn’t] like talking about mine because it was all self inflicted eh.  It 
was all really my fault.  So it was like that’s ma business eh (Bobby, Male, 32 
years old)  
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The above shows that for some PWID, learning about SSTI was gained from 
personal experience whilst others gained awareness from their peers.  
 
The experience of, and learning gained from having a SSTI can also leave some 
PWID, such as Allan, viewing SSTI as an experience not to be repeated: 
I don’t want another abscess, trust me.  The pain was excruciating. (Allan, 
Male, 34 year old) 
 
Personal responsibility and agency 
Awareness of the unacceptable social or physical consequences of SSTI fostered a 
sense of personal responsibility and agency in some PWID which, in turn, 
encouraged wound care or the use of HR techniques to avoid future infection. 
However, whilst it was commonplace for HR to be introduced or used more 
frequently since a SSTI, some PWID did not consciously associate this with 
addressing SSTI or they considered SSTI to be unpredictable: 
But see, see to tell you the truth, you, you don’t, you dinnae [didn’t] 
even really know when you’re gonnae [going to] get them because one 
time you could get yourself in the vein and it can turn intae an abscess.  
Or another time you can miss and it doesnae turn intae [does not turn 
into] an abscess.  Another time you can miss and it does turn intae an 
abscess.  (Amy, Female, 34 year old) 
 
Dave, who considered the unsightly symptoms as socially unacceptable, was 
prepared to look after his abscesses, indicating a level of personal responsibility and 
awareness of the need to manage and minimise any symptoms: 
They don’t bother me because I don’t let them get…I don’t let them get out a’ 
control.  I know people and they do nothing about them.  And they’re stinking 
and it’s, it’s horrible.  And there’s no need for it. . . . Well I, I use antiseptic 
swabs morning, noon and night.  I dress them meself wi’ iodine and…and 
patch [bandages] . . . Yeah, yeah but if it gets too bad I’ll go tae a doctor and 
get a course a’ antibiotics and then, or else he’ll slit it or taken intae a hospital, 
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depending on how bad it is or where on the body is it. (Dave, Male, 40 year 
old) 
Many participants practised skin swabbing. Brian, who had been hospitalised with 
cellulitis, engaged in consistent swabbing to help avoid another infection: 
Well, like I said, I’m swabbing mair [more]. Do you know what I mean? 
To make sure that it’s no’ happening. It’s the last thing I want. I dinnae 
[don’t] want that again. Naebody [Nobody] wants it. (Brian, Male, 42 
years old) 
And, as noted by Patricia, the provision of swabs in the ‘one hit kits’ (a pack 
containing a sterile N/S, spoon, filter, wipe/swab and citric acid sachet for a single 
injection) was beneficial:  
‘Cause especially wi’ the one hit kits now. Like, before when you got 
your tools, …  probably a Sterex wasnae the first on your – you know, 
you wouldnae [would not] really think ‘Oh, I need a Sterex.’ But when 
it’s in the one hit kit and it’s there for you to use, I think you’re more 
likely to use it, you know? (Patricia, Female, 34 years old) 
However, despite the supply of swabs in the ‘one hit kits’, they were not always used 
for the intended purpose: 
Getting them quite regular.  Always making sure that I’ve got new, new 
clean needles and swabs.  A’, a’ the paraphernalia, the cookers, 
everything.  But one a’ the things that I didnae dae [didn’t do] and I 
should have done during ma using was the swabs.  I didnae clean 
maself often enough before I, before I had the injection. …  But it’s like 
another thing, you know, because you’ve got about ten things tae dae 
[to do] before you actually get the hit.  And it’s building up and building 
up, a’ the excitement, everything.  And then so I’ll just say the less 
work [to] get this hit, get this. (Sam, Male, 49 year old) 
John used his wipes to clean the injecting equipment and to get a better flame: 
Just maybe cleaning my pot, or if my lighter’s no’ very good, lighting 
the swab because that’s got alcohol in it and gies [gives] you a flame 
tae [to] cook the hit up. (John, Male, 45 years old) 
A few participants noted that pre-injection wipes were not necessary as they 
showered or bathed before injecting to help them locate surface veins. Others would 
use baby wipes or alcohol wipes post-injection rather than pre-injection.  
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Other HR introduced following a SSTI included: improved general cleanliness, 
staying away from squalid injecting settings, taking time to inject to avoid missing, 
keeping to surface veins by using 1ml N/S to avoid digging for deeper veins, using a 
sterile needle for each attempt, increasing the quantity of injecting equipment 
collected from a NSP (for example, from 10-20 N/S to a box of 100 N/S), reducing 
injecting frequency, regularly getting injecting wounds checked by a nurse, and 
abstaining from groin injecting or NPS. Notably, some injecting changes made would 
be ineffectual or counter-productive, such as, boiling the drug solution more to 
remove black flecks or using more citric acid. 
 
Also, a transition to smoking was undertaken by some. Allan transitioned to smoking 
to reduce his injecting frequency and to allow his abscess to heal: 
But I’ve sorta stopped going into my arms just to let them heal.  I’m 
smoking now at the moment.  But I…I…I’m not gonna [going to]  lie to 
you, I miss injecting too much.  I miss the high of the injection. (Allan, 
Male, 34 year old)  
Later on in the interview, he admitted to occasionally injecting into the veins in his 
hand.  However, Patricia, who had transitioned to smoking since getting an upper 
arm abscess, acknowledged this was because of the difficulty getting a vein rather 
than avoiding a SSTI per se. For some, smoking or snorting was not an option 
because of poor quality heroin, injecting being better and more cost effective, lung 
problems, and sharing drugs with another injector. 
 
It was rare for participants to practise injection site rotation prior to or since their 
SSTI. The same injecting site was re-used to ensure another successful hit as 
explained by Eric and Liam:   
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…if you have success with the hands from the previous time, that’s what I 
would go for the next time because I thought “Well, it worked the last time.”  
… cause veins do not pop up very much, it’s difficult to even see them, never 
mind actually hit them. (Eric, Male, 61 years old) 
…cause I got it the last time and I, I know sort of what angle to go in at.  Some 
a’ them could be quite a bit deep under the skin, yeah. (Liam, Male, 36 years 
old) 
Furthermore, Liam explained that he was unaware of injection site rotation and 
would re-use the same vein until it was damaged before moving onto another vein: 
See I didn’t realise that site rotation was so important when I started 
injecting.  And to be honest when I first started injecting, my, my main 
goal was suicide really, yeah.  And but…yeah I would always use one 
vein until it, it was damaged and then move on to the next. … Then I 
got to the point where I was lucky if I found one.  (Liam, Male, 36 years 
old) 
However, Pete, who despite been advised by a friend to practise injection site 
rotation, justified not doing so because he did not want to use alternative injecting 
sites that he could not conceal and thus avoid social stigma:  
I Okay. So, why always go in the same [injecting body site]? 
R I don’t know. I think it was just so I didnae [didn’t] get track 
 marks up and doon my airms [down my arms]. … Well, when I – 
 when I first started injecting, my mate telt me ‘a’ways go, dae it 
 here once, there once, there, just dae a box’ [my mate told me 
 always do it here once, there once, there, just do a box} 
 [PARTICIPANT POINTED TO LOWER RIGHT AND LEFT 
 ARM]. So, if I dae that I’m gie’in myself [So, if I do that I’m giving 
 myself] a chance to heal. … And I’ll no’ end up wi’ marks. But I 
 was dae’in [doing it] it that much then I had a mark here, here, 
 here, and here, and I looked like a pure state. (Pete, Male, 28 
 years old) 
For some, such as Patricia, not being aware of and not practising injecting site 
rotation was a cause of regret: 
“… I just wish I had rotated my veins more. And I wish I was more 
aware of it when I first started injecting. You know? I’d have probably 
done it. ‘Cause I did have good veins at one time but they’ve packed in 
now.” (Patricia, Female, 34 years old) 
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Personal responsibility for SSTI was also seen in the reasons PWID gave for 
developing these infections. Many participants blamed their own injecting technique, 
or lack of it. 
 
Missing the vein was cited as a cause of SSTI through struggling to inject into 
damaged veins or from a lack of confidence in technique as noted by Allan who had 
an abscess in the crook of his arm: 
Yeah a missed hit but I think, but the thing is I’m not the best hitter.  I’m no 
gonnae lie tae you right [I’m not going to lie to you].  I’m not the greatest hitter.   
. . . but now my veins…are paying the price for it, I think.  You know, now 
cause I’ve been missing it a lot.  It’s like I’m really starting…tae get scared 
aboot it [to get scared about it] (Allan, Male, 34 year old) 
Or from shaky hands as noted by John: 
Sometimes I dinnae [didn’t] have the needle right in, like against my 
skin and the needle might be out a bit when I find the vein, so, I’ll try 
and hold it in that position. But it depends, you know, shaky hands 
and stuff like that. You end up missing at times. (John, Male, 45 years 
old) 
Reliance on assisted injecting was also implicated for causing missed hits by Patricia 
and Danny who both noted that the assisting injector can be careless, inexperienced, 
unaware they have caused a problem or impatient to get their own hit. This can even 
be an issue when the person assisting was trusted: 
I thoroughly believe that the person was genuinely trying to get me, but 
unfortunately they missed.  Right?  But they’re in, maybe they’re in a 
rush for their ain stuff, or maybe whatever.  Maybe just lack o’ 
knowledge o’ trying tae get it right an’ they’ve inadvertently burnt me 
an’ caused the abscess. . . . It’s gottae be people I know an’ people I 
have, I can trust.  But even people you trust, you can still end up with 
abscesses an’ such like. (Danny, Male, 43 years old)  
 
Although struggling to inject was not always given as an explanation for their SSTI, it 
was a recurrent theme raised during descriptions of injecting experiences. Eric 
described deliberate muscle popping:  
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Sometimes if I just haven’t been able to get a vein after, say, three 
tries, I’ll just put it into muscle. (Eric, Male, 61 year old)  
Struggling to inject resulted in some PWID resorting to surface veins or central veins, 
such as the groin. 
 
Groin injecting was commonplace and was associated with practical injecting 
difficulties. Caroline, who had a groin abscess, in general guessed whether she had 
hit the femoral vein and acknowledged she probably misses. Similarly, Tanya, who 
had been hospitalised for a groin abscess and DVT, noted that despite injecting into 
her groin she did not know what she doing: 
Well ma ex, he was the one that marked me.  I just seen the hole and 
thought I could go intae it [into it].  And didnae [didn’t] realise what I 
was doing.  I was hitting a nerve, artery, punctured ma artery.  Ended 
up wi’ DVT, everything.  Just using blunt needles, using used tools, 
using wi’ other people. (Tanya, Female, 21 years old)  
In addition, struggling to inject resulted in injecting equipment supplies being quickly 
depleted:  
It’s too much trouble you can spend ower an hour over mair just tae 
[over an hour, over more just to] get it.  And then you could have five 
sets to start with and you end up getting, you’re on the last one. (Hugh, 
Male, 53 years old)  
Depletion of injecting equipment could lead to re-use of needles, seen as a cause of 
SSTI by some participants.  
 
Needles were re-used because of lack of time or inability to replenish supplies due, 
for example, to weekend closing of convenient NSP or if they woke in the middle of 
the night: 
A chaotic life situation that I was in at the time, that I had to re-use 
because there isnae [isn’t] really any excuse for it, there’s exchanges 
everywhere in [NAME of CITY], do you know what I mean? And there’s 
a 24 hour one … Aye, so, there’s really no excuse for – but maybe 
time. Like, if it’s early hours and, you know, if you’re using, if you’ve 
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woke up and it’s, like, half one or whatever and you’re gonnae [going 
to] have a charge then you’ve ran out of tools or whatever then, like, 
you just think ‘Ach, I’ll use that one I used earlier. (Patricia, Female, 34 
years old) 
The tendency was to re-use needles and syringes (N/S) twice or three times, with 
some acknowledgment that the needles were probably barbed, had not been 
cleaned or only rinsed, and had been taken out of a ‘cin-bin’ (incineration bin used 
for the safe disposal of sharps) or a bag as described by Tanya: 
Needles, couldn’t be bothered walking to [NAME of EXCHANGE] because a’ 
the pain I was in.  I just went to the cin-bin [sharps bin] and took, took a few 
used, and some a’ them were barbed.  I didn’t know what a barbed was cause 
I never got told. (Tanya, Female, 21 years old) 
 
However, Sam who admitted to re-using the same needle up to 10 times, 
acknowledged that a photograph of a barbed needle, displayed in a drug treatment 
centre, had impact: 
I Did you know [about barbed needles]? 
R No, I forgot.  No I didnae [didn’t] know that it was as bad as that 
photae.  And when I seen that photae, how a needle looks when 
blunt, I was like, ‘what!’.  Didnae [didn’t] know that.  That’s, that’s 
a, that is a pure absolute cracking photae.  You know, it’s 
amazing that photae.  If I’d have seen that years and years ago I 
woulda’ definitely have thrown them things away. (Sam, Male, 
49 years old) 
Reasons for re-using, despite picking up plenty of N/S, included had given them 
away to others or had been accidentally supplied with the wrong sized needles and 
preferring to re-use than use the wrong needle.  Re-using one’s own N/S is 
considered protective against N/S sharing (Rhodes, Davis, & Judd, 2004) but may 
not prevent vein damage and the development of SSTI.   
 
Social and physical environment risks 
Some SSTI risks were out-with the individual control or personal agency of PWID. 
For example, drug composition constitutes a physical/pharmacological risk 
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environment over which PWID have no control (Elliott et al, 2018; McGowan et al, 
2017). Some PWID believed that the drug or adulterants had caused their SSTI 
because the drug did not look right, they generally practised safe injecting or they 
had used a different dealer from their usual.  In particular, NPS injecting was 
implicated as the cause of SSTI by some participants. Danny, who had experienced 
abscesses whilst injecting NPS, noted its ‘corrosive’ effect on the skin because of 
ingredients such as ‘draining fluid’ or ‘oven cleaning fluid’ and Mike considered:   
It’s chemicals inside the legal highs, I think. It’s all it could be. Never had 
anything like that wi’ heroin so it’s a chemical inside the legal highs. It’s gotta 
[got to] be. (Mike, Male, 33 years old) 
 
However, a squalid physical risk environment, was also described by those injecting 
NPS, which could be implicated as causing SSTI.  The most commonly injected NPS 
in Lothian at the time of the study was ‘Burst’ which contained the stimulant 
ethylphenidate (Lafferty et al, 2016). Pete described his experience whilst injecting 
‘Burst’.  
In the place I was sitting, ‘cause some o’ the places I was sitting when 
I was on that Burst were nae better than Trainspotting. … Bloody 
swabs all aboot the place, uncapped needles, cin-bins [sharps bins] - 
unused dirty works and in juice bottles. … It was like sitting in the kerb 
doon near the rubbish. (Pete, Male, 28 year old) 
Furthermore, Pete acknowledged sharing N/S whilst injecting Burst, suggesting that 
his previously established HR practice was being hindered: 
R But, see wi’ heroin? Wi’ heroin, you didnae [didn’t] bother, if you 
couldnae [could not] get a needle, you didn’t [inject], you went 
withoot [without]. But wi’ this stuff [Burst], it was unbelievably 
addictive.   
I Right. 
R An’ it was really, really bad. You didnae care, you didnae bother 
and it didnae matter if the blood, the barrel was see-through or it 
was bright pink, bright red. It was, it was in the blood, you ended 
up taking it. Ken [Do you know what I mean}, it was disgusting, 
what [BURST] would actually dae to your heid [do to your head]. 
I Aye. Aye. 
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R Ken [Do you know what I mean]  ‘cause they usually tell you 
that’s wrong, dinnae dae [don’t do it] it, wi’ heroin. But this stuff, 
you just – you switched off.  
 (Pete, Male, 28 years old) 
 
 
DISCUSSION  
Our study is one of the few qualitative studies to have explored PWID views and 
experiences of their SSTI, perceived causes of SSTI and use of HR.  A number of 
themes emerged including: impact of SSTI, knowledge of SSTI, personal 
responsibility and agency, and the social and physical risk environment. We found 
that the experience of SSTI can cause strong negative feelings, including panic and 
stigma and that there was limited second hand learning from peers about SSTI. 
None of the respondents mentioned learning about SSTI prior to experiencing them 
from services such as NSP. The awareness of the unacceptable social and physical 
consequences of SSTI fostered a sense of personal responsibility and agency which 
led to the introduction or improved HR uptake. However, when PWID were struggling 
to inject or when their social environments were compromised there was an 
increased risk for SSTI and reduced effectiveness of HR.   
 
In general, interventions are needed to enable PWID to exercise personal 
responsibility and agency over preventing and dealing with SSTI while also 
addressing the lack of SSTI awareness and knowledge, practical injecting difficulties 
and the risk environment. There is a need to provide advice and information, address 
individual level behaviour change and structural level change.  
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SSTI advice could include the signs and symptoms, wound care, HR and sources of 
healthcare. This may help some PWID to feel less stigmatised and panicked by 
SSTI, aid prevention and encourage timely healthcare seeking. Safer injecting 
advice could include for example, showing PWID how to find a vein to avoid missed 
hits, and should promote injection site rotation and route transition. We found that 
PWID were reluctant to practice HR such as vein care and route transition before or 
since their SSTI.  This was because of poor awareness of injection site rotation, a 
lack of viable veins, a reluctance to use alternative injection sites that cannot be 
concealed, and a preference for injecting over other consumption routes. Pragmatic 
vein care advice has been advocated for PWID having difficulty injecting (Harris & 
Rhodes, 2012). Vein care advice may be more effective for those PWID 
disenfranchised with route transition advice (Harris & Rhodes, 2012). Our findings 
show that some PWID did not consider route transition viable and the few PWID who 
transitioned to smoking/snorting did so either temporarily to allow SSTI wound 
healing or their reason was unrelated to preventing SSTI.  
 
Such awareness raising may be needed for all PWID regardless of duration of 
injecting. In our sample, poor knowledge of SSTI was not necessarily associated 
with new initiates to injecting. Our PWID had been injecting for on average 15 years, 
with none having a duration of injecting of less than five years, and some were 
experiencing their first ever SSTI after five years injecting. This may indicate a group 
of PWID for whom their first SSTI was a consequence of prolonged injecting 
histories, for example, from venous damage. 
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Our findings also suggest that any HR interventions which focus on the unacceptable 
consequences of SSTI, including the stigma, unsightly visible marks, swellings and 
pain, rather than health promotion may be effective.  This is supported by previous 
work that found body image management, namely avoiding track marks and 
scarring, was a rationale given by HCV negative PWID for engaging with HR rather 
than HCV prevention or vein maintenance (Harris, Treloar, & Maher, 2012). 
 
However, behavioural and individual level HR interventions and messages may be 
limited in effectiveness without a recognition of the limitations imposed by the risk 
environment (Moore, 2004). Interventions also need to address the compromised 
social, physical and political environments (Tim Rhodes, 2002, 2009) exposing 
PWID to i) injecting equipment shortages, ii) squalid injecting environments, iii) 
withdrawal and iv) adulterated drugs.  These experiences, alongside struggling to 
inject, underpin the risk behaviours and compromised HR practices putting PWID at 
risk of SSTI.  Consistent with findings from other studies which examined SSTI and 
injecting (Phillips et al., 2012) or injecting in general (Moore, 2004; Neale, 2002; 
Taylor A., Fleming A., Rutherford J., & Goldberg, 2004)  the PWID in our study were 
re-using N/S, injecting sub-cutaneously or intra-muscularly, inexpertly groin injecting, 
reliant on assisted injecting and not consistently swabbing.  These behaviours have 
been found to be risk factors for SSTI (Dunleavy et al., 2017; Hope, Hickman, Parry, 
& Ncube, 2014; Hope, Kimber, Vickerman, Hickman, & Ncube, 2008; Larney et al., 
2017; Lloyd-Smith et al., 2008; Murphy et al., 2001) .   
 
 ‘Safer environment interventions’ have been identified as mitigating against the risk 
environment and include peer-based harm reduction interventions, NSP provision 
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and supervised injection facilities (McNeil & Small, 2014; T. Rhodes et al., 2006) . 
They produce social, structural and physical settings for HR whilst providing access 
to social and material resources, such as advice, injecting equipment supplies and 
healthcare. 
 
Peer based support interventions 
There are many examples of peer-based interventions that have provided HR, 
advice and health services (Marshall, Dechman, Minichiello, Alcock, & Harris, 2015) . 
Abscess management, among other injecting related harms, has been facilitated 
through the provision of peer-to-peer out-reach education and assistance to promote 
safer injection techniques at the point of injection (Small et al., 2012). This has been 
delivered to those engaged in public or semi-public injecting via drug-user-led 
‘Injection Support Teams’. The advice provided included injection techniques, safer 
injection practices, route transition advice and verbal instruction promoting self-
administration of injections. However, peer interaction needs to be frequent, for 
example Jain et al. (2014) found that three or more sessions per month were 
associated with behaviour change such as reduced N/S sharing (Jain et al., 2014). 
Other means of delivering advice and education are needed for PWID not engaged 
in public injecting. The ‘Injection Support Teams’ also provided peer-led workshops 
including education on bacterial infections from drop-in centres and single room 
occupancy hotels (Callon, Charles, Alexander, Small, & Kerr, 2013). 
 
Structural interventions 
Structural level interventions, such as improved NSP provision and medically 
supervised injecting facilities should also be considered for prevention of SSTI.  
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In order to ensure adequate individual-level N/S coverage, to prevent N/S re-use, 
policies governing injecting equipment distribution may need to be scaled up. 
Homelessness and public injecting have been found to be associated with a ‘syringe 
gap’, that is, an inadequate number of N/S for the number of injections (Bluthenthal, 
Anderson, Flynn, & Kral, 2007; Heller, Paone, Siegler, & Karpati, 2009).  This 
suggests a need to scale-up street based outreach or peer distribution, and 24 hour 
NSP access. In addition, PWID could also be offered a postal service where practical 
(European Monitoring Centre for Drugs and Drug Addiction, 2016). However, 
expansion of injecting equipment distribution without also offering a more client-
tailored NSP service that addresses PWID social disadvantages, poor physical and 
mental health will not eliminate risky injecting practices (Treloar, Mao, & Wilson, 
2016). 
 
Medically supervised injecting facilities could also be instrumental in raising 
awareness and helping PWID avoid SSTI.   Although there is no evidence on the 
impact of supervised injecting facilities on the prevalence and incidence of SSTI, it 
has been perceived by healthcare staff and users that safer injecting education 
delivered within a supervised injecting facility had resulted in a reduction in abscess 
occurrence (Fast, Small, Wood, & Kerr, 2008; Krüsi, Small, Wood, & Kerr, 2009). 
Education included how to find a vein, tourniquet use, hygienic use of a filter (Wood 
et al., 2008).  In addition, the facility was found to increase access to nurses offering 
SSTI assessment and healthcare and facilitated timely hospital referral for the more 
serious SSTI (Lloyd-Smith et al., 2009; Wood et al., 2008). It was not the safer 
injecting education per se but it’s timely delivery within the supportive environment of 
a supervised injecting facility that heightened PWID awareness and diligence, and 
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enabled safer injecting to become habit forming both onsite and outside the 
supervised injecting facility (Fast et al., 2008). Furthermore, the more hygienic space 
of a supervised injecting facility coupled with access to a readily available supply of 
sterile N/S at the point of injection may for some PWID mitigate against physical risk 
environments. 
 
Although there were no differences in the PWID views and experiences across the 
two recruitment sites SSTI associated with NPS injecting was only experienced 
within NHS Lothian.  NPS (ethylphenidate) injecting was more prevalent in NHS 
Lothian and had been implicated in an outbreak of bacterial infections, including 
SSTI (Lafferty, Smith, Coull, & Shanley, 2016).  This highlights a need for localised 
drug-specific as well as general HR advice. For example, drug-specific advice was 
needed for the NPS injectors as the process of drug preparation for injecting 
ethylphenidate is different from heroin (for example, there is no need to heat the drug 
solution or to use citric acid). 
 
There are a number of limitations with the study. As in all qualitative studies, our 
sample was small and the findings cannot be generalised to other settings. Our 
participants were drawn from a drug treatment and a NSP service, one of which 
provided a wound clinic.  This may have heightened some participants’ willingness to 
engage with HR since their SSTI.  In addition, our study did not include PWID 
without experiences of SSTI – this group may have avoided SSTI by increased 
awareness and HR implementation;  
 
Implications for research, policy and practice 
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Further research is needed to assess the impact of NPS injecting on HR.  Our 
findings also highlight the compounding effects of drugs as illustrated by the use of 
NPS. NPS injection has been associated with SSTI (Dorairaj, Healy, McMenamin, & 
Eadie, 2012; Health Protection Scotland & NHS NSS, 2015; Van Hout & Bingham, 
2012).  Our findings add to this by suggesting previously adhered to HR may be 
being abandoned when injecting NPS – as highlighted by the sharing of N/S and the 
squalid physical injecting environments. The mechanisms for this are unclear, 
whether it is a product of the social environment, such as the peer group norms of 
the injecting scene, and/or the psychoactive effect of NPS.  
 
Compared to HCV and HIV, SSTI as an injecting related harm has received less 
policy attention. This may in part help to explain the limited learning or awareness 
about SSTI until experienced first-hand. This coupled with the stigma associated with 
SSTI highlighted a need for awareness raising and sharing of SSTI experiences. Our 
findings also show that PWID experience constraints within their physical and social 
environments that influence their injecting experiences and disrupt HR practices 
increasing their risk of SSTI. Consequently, policy makers need to address SSTI HR 
within enabling environments, such as ‘safer environment interventions’. It is 
recommended that peer based support, improved NSP provision and medically 
supervised injecting facilities are needed to deliver SSTI HR. 
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